Open access · CC-BY
via OpenAlex
Urolithin A provides cardioprotection and mitochondrial quality enhancement preclinically and improves human cardiovascular health biomarkers
Sophia Liu, Julie Faitg, Charlotte Tissot, Dimitris Konstantopoulos, Ross Laws, Guillaume Bourdier, Pénélope A. Andreux, Tracey Davey, Héctor Gallart‐Ayala, Julijana Ivanišević, Anurag Singh, Chris Rinsch, David Joseph Marcinek, Davide Francesco D'Amico
iScience · 2025 · ▲ 39 citations
Abstract
Cardiovascular diseases (CVDs) remain the primary cause of global mortality. Nutritional interventions hold promise to reduce CVD risks in an increasingly aging population. However, few nutritional interventions are proven to support heart health and act mostly on blood lipid homeostasis rather than at cardiac cell level. Here, we show that mitochondrial quality dysfunctions are common hallmarks in human cardiomyocytes upon heart aging and in chronic conditions. Preclinically, the post-biotic and mitophagy activator, urolithin A (UA), reduced both systolic and diastolic cardiac dysfunction in models of natural aging and heart failure. At a cellular level, this was associated with a recovery of mitochondrial ultrastructural defects and mitophagy. In humans, UA supplementation for 4 months in healthy older adults significantly reduced plasma ceramides clinically validated to predict CVD risks. These findings extend and translate UA's benefits to heart health, making UA a promising nutritional intervention to support cardiovascular function as we age.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.isci.2025.111814
- Canonical
- link ↗
- Fetched
- 2026-11-09 MST
Cite this
APA
Liu, S., Faitg, J., Tissot, C., Konstantopoulos, D., Laws, R., Bourdier, G., Andreux, P.A., Davey, T., Gallart‐Ayala, H., Ivanišević, J., Singh, A., Rinsch, C., Marcinek, D.J., & D'Amico, D.F. (2025). Urolithin A provides cardioprotection and mitochondrial quality enhancement preclinically and improves human cardiovascular health biomarkers. <em>iScience</em>. https://doi.org/10.1016/j.isci.2025.111814
Vancouver
Liu S, Faitg J, Tissot C, Konstantopoulos D, Laws R, Bourdier G, et al. Urolithin A provides cardioprotection and mitochondrial quality enhancement preclinically and improves human cardiovascular health biomarkers. iScience. 2025. doi:10.1016/j.isci.2025.111814.
BibTeX
@article{sophia2025Urolit,
title = {Urolithin A provides cardioprotection and mitochondrial quality enhancement preclinically and improves human cardiovascular health biomarkers},
author = {Sophia Liu and Julie Faitg and Charlotte Tissot and Dimitris Konstantopoulos and Ross Laws and Guillaume Bourdier and Pénélope A. Andreux and Tracey Davey and Héctor Gallart‐Ayala and Julijana Ivanišević and Anurag Singh and Chris Rinsch and David Joseph Marcinek and Davide Francesco D'Amico},
journal = {iScience},
year = {2025},
doi = {10.1016/j.isci.2025.111814},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
bioRxiv (Cold Spring Harbor Laboratory) 2023
Preprint · OA
Urolithin A induces cardioprotection and enhanced mitochondrial quality during natural aging and heart failure
Korean Circulation Journal 2020
Open access · CC-BY
Mitochondrial Quality Control in the Heart: New Drug Targets for Cardiovascular Disease
Frontiers in Physiology 2020
Open access · CC-BY
Mitochondrial Quality Control and Cellular Proteostasis: Two Sides of the Same Coin
Amazentis SA 2023
Open access · US-GOV
Impact of Urolithin A Supplementation on Mitochondrial Health of Immune Cells (MitoImmune): a Randomized Trial
Healthy ageing and longevity 2026
Citation only
NAD+ and Its Precursors for Health and Longevity
Medicine & Science in Sports & Exercise 2022
Citation only